Monoclonal Gammopathy of Undetermined Significance clinical trials
The registry lists 102 studies for Monoclonal Gammopathy of Undetermined Significance across more than 10 countries. 28 are recruiting or about to start. 29 of them are mainly about Monoclonal Gammopathy of Undetermined Significance (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-29.
Get an email when these change. Save the Monoclonal Gammopathy of Undetermined Significance studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Who runs them
Mayo Clinic (7) · Memorial Sloan Kettering Cancer Center (6) · National Cancer Institute (NCI) (6) · European Organisation for Research and Treatment of Cancer - EORTC (4) · SWOG Cancer Research Network (3) · Dana-Farber Cancer Institute (3) · Wake Forest University Health Sciences (3) · Jonsson Comprehensive Cancer Center (3)
What is being tested here
Drugs under test in Monoclonal Gammopathy of Undetermined Significance studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Curcumin | 1 | 0 | 2 |
| Omega-3 fatty acid | 1 | 0 | 2 |
| Florbetaben f-18 | 1 | 0 | 1 |
| Probiotic | 1 | 0 | 1 |
| Linvoseltamab | 1 | 0 | 1 |
| Darbepoetin alfa | 0 | 1 | 2 |
| Morphine | 0 | 1 | 2 |
| Epoetin Alfa | 0 | 0 | 2 |
| Caspofungin | 0 | 1 | 2 |
| Zanubrutinib | 0 | 0 | 1 |
Drug classes tested here Antimetabolites 4 · Tyrosine kinase inhibitors (TKIs) 3 · Alkylating agents 3
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 5
- Nov 2026A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM) · Memorial Sloan Kettering Cancer Center
- Dec 2026Zanubrutinib Treatment in Patients With IgM Monoclonal Gammopathy and Antri-MAG Related Polyneuropathy · UMC Utrecht
- Feb 2027Quality of Life in Patients With Asymptomatic Monoclonal Gammopathies · M.D. Anderson Cancer Center
- Jul 2027Two Biologically and Clinically Distinct Entities: Progressive Versus Stable Multiple Myeloma (MM) Precursor Conditions · University of Miami
- Sep 2027A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS) · Memorial Sloan Kettering Cancer Center
Who these studies take
Of the 20 Monoclonal Gammopathy of Undetermined Significance studies recruiting now, 18 (90%) set no upper age limit and 0 (0%) stop at 75 or younger. 1 (5%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 5 (25%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 1 (5%) | 1 (5%) |
| 18 | 18 (90%) | 18 (90%) |
| 30 | 19 (95%) | 19 (95%) |
| 40 | 19 (95%) | 19 (95%) |
| 50 | 20 (100%) | 20 (100%) |
| 65 | 20 (100%) | 20 (100%) |
| 75 | 20 (100%) | 20 (100%) |
| 85 | 20 (100%) | 20 (100%) |
Across all 102 studies, recruiting or not: 8% stop at 75 or younger and 4% at 65; 17% take children; 1% are for women only and 1% for men only; 10% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 50 of 102. Browse all 102 → or search them.
- The Indiana Myeloma RegistryRecruitingNCT036164831 country
- Observational Prospective Research Study In Monoclonal Gammopathies leadINg to MyelomaRecruitingNCT027267501 country
- Quality of Life in Patients With Asymptomatic Monoclonal GammopathiesRecruitingNCT051368071 country
- A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)RecruitingNCT06055894Not applicable1 country
- A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFHRecruitingNCT052839931 country
- Evaluating the Impact of a 12-month Multi-Modal Lifestyle Management Intervention on Disease Relevant BiomarkersNot yet recruitingNCT06987708Not applicable
- Rifaximin Versus No Intervention for the Treatment of IgG/IgA (Non-IgM) Monoclonal Gammopathy of Undetermined SignificanceRecruitingNCT07209371Phase 21 country
- MGUS/MM Awareness and Genetics Insights Campaign (MAGIC) Screening StudyEnrolling by invitationNCT064728301 country
- CHAAMP (CHArlotte Advocate MGUS Project) Internal Pilot StudyRecruitingNCT066446251 country
- A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple MyelomaRecruitingNCT06140524Phase 27 countries
- Determine the Frequency of Variants in the GBA/PSAP Genes in Patients With MM or MGUSRecruitingNCT065590331 country
- Early Detection of Amyloidosis in Monoclonal Gammopathy Using Nuclear Medicine ImagingNot yet recruitingNCT07624760Not applicable1 country
- Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical OutcomeRecruitingNCT022695921 country
- FAST-M: Prolonged Overnight Fasting and Mediterranean Dietary Intervention for Patients With Multiple Myeloma or Its Precursor DiseaseRecruitingNCT07446777Not applicable1 country
- Integrative Multi-omics Analysis to Predict Monoclonal Gammopathies Clinical EvolutionRecruitingNCT072143241 country
- Promoting Diagnosis and Management of AL in Italy (ProDigALIty)RecruitingNCT063831431 country
- A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)RecruitingNCT05640843Not applicable1 country
- Two Biologically and Clinically Distinct Entities: Progressive Versus Stable Multiple Myeloma (MM) Precursor ConditionsRecruitingNCT053616941 country
- Clonal Hematopoiesis of Immunological SignificanceNot yet recruitingNCT059698211 country
- Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample ResourceRecruitingNCT014082251 country
- Exploring the Effects of Korean-Style Mediterranean Diet (KORMED) and Physical Activity Measurement in Patients With MGUS/SMM: A Pilot StudyNot yet recruitingNCT07305662Not applicable1 country
- A Study of Carbon 13-based Deep Labelling of Bone Marrow CellsEnrolling by invitationNCT070575831 country
- Sleep Apnea in Patients With MGUS and MMRecruitingNCT041140841 country
- Whole Body MRI in OncologyRecruitingNCT068952911 country
- Characteristics and Clinical Significance of Gut Microbiota in Patients With Monoclonal GammopathyRecruitingNCT066905931 country
- Screening for Monoclonal Gammopathy in Individuals Undergoing Physical Examinations Using iMS-LC Assay Technology.Not yet recruitingNCT064896131 country
- The China M-protein Screening Project in First-degree Relatives of Myeloma Patient - The CHAPERONE StudyRecruitingNCT059651151 country
- Establishment of Genomic, Transcriptomic and Functional Characteristics of Tumor Cells in Hyperinflammatory HemopathiesNot yet recruitingNCT047029321 country
- A Study of a Plant-Based Diet in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)Active, not recruitingNCT04920084Not applicable1 country
- Early Detection of Multiple Myeloma to Fight Cancer Disparities: A Screening and Patient Navigation ProgramActive, not recruitingNCT05831358Not applicable1 country
- Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate CancerCompletedNCT04731844Phase 21 country
- Zanubrutinib Treatment in Patients With IgM Monoclonal Gammopathy and Antri-MAG Related PolyneuropathyActive, not recruitingNCT05939037Phase 21 country
- Investigation of Metformin for the Prevention of Progression of Precursor Multiple MyelomaActive, not recruitingNCT04850846Phase 21 country
- Imaging in MGUS, SMM and MMCompletedNCT01237054Phase 21 country
- Daratumumab for Polyneuropathy Associated With MGUSWithdrawnNCT06046287Phase 21 country
- Iceland Screens, Treats or Prevents Multiple MyelomaActive, not recruitingNCT03327597Not applicable1 country
- The Development and Pilot Testing of a New MR Imaging Protocol to Quantify Myeloma Disease Burden and Bone LossCompletedNCT039512201 country
- Observation of the Incidence and Natural History of MGUS in Patients Undergoing Weight Reduction SurgeryCompletedNCT038558781 country
- Screening to Improve Survival in AL AmyloidosisCompletedNCT046155721 country
- B-Cell Hematologic Malignancy Vaccination RegistryWithdrawnNCT022988161 country
- Dysregulation of Glutamine Activity in the Pathogenesis of Multiple MyelomaCompletedNCT03119883Not applicable1 country
- A Study of KW-2478 in Combination With Bortezomib in Subjects With Relapsed and/or Refractory Multiple MyelomaCompletedNCT01063907Phase 1/23 countries
- Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell TransplantCompletedNCT01588015Phase 11 country
- Ibrutinib for the Treatment of COVID-19 in Patients Requiring HospitalizationCompletedNCT04439006Phase 11 country
- Isatuximab in Type I CryoglobulinemiaStatus unknownNCT05114109Phase 2
- Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal MetastasesCompletedNCT00424242Early Phase 11 country
- MGUS, SMM, and MM Patient Experience With Coronavirus 19 (COVID-19) SurveyStatus unknownNCT047272941 country
- Study of DNA Copy Numbers Variations and Gene Expression Profile of Bone Marrow Plasma Cells From MGUS and SMM.TerminatedNCT010794291 country
- Natural History Study of Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Myeloma (SMM)TerminatedNCT011094071 country
- Methadone, Morphine, or Oxycodone in Treating Pain in Patients With CancerTerminatedNCT00726830Not applicable1 country